{"name":"Catabasis Pharmaceuticals","slug":"catabasis-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CAT-2054-C","genericName":"CAT-2054-C","slug":"cat-2054-c","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"CAT-2054-C","genericName":"CAT-2054-C","slug":"cat-2054-c","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1iaEZ1UVg1T24zZ2Uwb2VBVFRnMzlCeExRUkZ4cmJ6bmFxNjA2eHNtTDN0aFdhNkUwVmZwVHVSUVhzQTdIanBqV3gzRkJzbXROVHhRdnlYeUNndDZSUjVyYXNIMWUxbUkzOXc?oc=5","date":"2025-08-19","type":"pipeline","source":"Wiley Online Library","summary":"Long-Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons - Wiley Online Library","headline":"Long-Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPYmVad2piaWdGN3FGb0tkU18yNFVPeDhSX0hpd0t2eXNEUG9OM3ZVN0pwRG5uX2Rrb2NXS0tjeXl6bF94a2tsOHk5YlNieHdxcExVd3g3UXlBbUpIVU4zck5aX3E5YW00azdfQjFzNEo3ZU1rQmxvSUlMY21VTExxRllmZjh3RGZaMlJrUA?oc=5","date":"2023-02-01","type":"pipeline","source":"Pharma Voice","summary":"Astria Therapeutics’ edge in an ultra-rare disease - Pharma Voice","headline":"Astria Therapeutics’ edge in an ultra-rare disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOSVdMb1ZVNmFJN1JfRlpBNWpaQk5WWnlOMW1SdDQ3VjJQdU5Vcm95aFdkcXMteWk4YmhMSmdsM1NoTjBldFRPSGNwX0JmdlV1ZzF1ZVV5NlJTUDJXaE1QTEtQNmZjWFJuS2dPbVBnNHJuUGxDOVJmejRYcUlleVVFUlB4VnF0ZTd1RHRqWXNTUS1tSUdJbTZwVWprdjI0SXBvNnRad3NlSnBWS2xsNHd4Z1J3X3c2SnJzNWdZaEo2MkFNQQ?oc=5","date":"2021-09-08","type":"pipeline","source":"Fierce Biotech","summary":"Catabasis Pharmaceuticals no more: Meet Astria Therapeutics, hoping to be a phoenix from the flames - Fierce Biotech","headline":"Catabasis Pharmaceuticals no more: Meet Astria Therapeutics, hoping to be a phoenix from the flames","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPaDF1azMtU2R6anp4Ym5OSVVSMlg1SnM1RWg1WFBvRWo4eE52QXMzQkNPTTJuLVdqUDdLRVZOSTFkQnpxbElUYWlDVmdTam5GdkNsYXR2ZXd2UG9ZbzhvN3V0OU5RLXlfY3VqdnJNcWJselA1Y0x3Mk5nOWpuUndJMmR2SVNaamgxbkxIZUJmUlhIeGVtTUxrQ2FOalVfNDZ2d3cta19iaVRXajY4Tk1jcTZMM1N0aGppelA1Tjk5WXlxTFlVZnpUNW00OXRuNl8w?oc=5","date":"2021-02-01","type":"pipeline","source":"WilmerHale","summary":"WilmerHale Advises Catabasis Pharmaceuticals in Acquisition of Quellis Biosciences - WilmerHale","headline":"WilmerHale Advises Catabasis Pharmaceuticals in Acquisition of Quellis Biosciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNV05YRmRuMzg3T1h4dlZhM0lySXRjc3dwT1RkUTRicDJEU051cG5BTjUzZXR4amdNcms3YlFLUUk0SE92SjNwcVkyeGhvU0tMQkR4SlZnd3ZGNkpEZVo0OUdIb19pNllzcUUwakdtSEhWcXZSNlloY0tPSTlNSEJTT1JnQVY3QQ?oc=5","date":"2021-01-25","type":"trial","source":"Fierce Biotech","summary":"2020’s top 10 clinical trial flops - Fierce Biotech","headline":"2020’s top 10 clinical trial flops","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNeWdTMndUZDFmTnFBbEJWTXd4YUhmazByRFUyZ0RtMVBoalVoVGkwUGVJX3B0dXk5bU5ad2RjZGNwU2JFUVZnUnJHN3B3aURBNE5lWEE2SlFSWHU5cjU4NjRCSzh4QmJfZW1Fb3hpXzR0TGhyLVZzdjZpS0cxQTRkaVc2c2gzMlVyMWx0SmdqaEtwck11QXhTTXdaeDJYOHhkZVl5eVJQZGQtVnFmaFFvVTRmSUM?oc=5","date":"2020-10-27","type":"trial","source":"statnews.com","summary":"Why did this small biotech blow up? Because spinning bad drug data never works - statnews.com","headline":"Why did this small biotech blow up? Because spinning bad drug data never works","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPREpFcUllUk9iaXZINjdhU2pxdDFnM1dpZlVfMkJ6ZXhtMVZUNGw2amdSTmFSUlJUTjRPNzYyMlgwNVRSbGpiUDh2Y09tc0trbGhvZ2tkYTJOQl8zVlhhcktGV2hPS05mM0hvWjZ1Rm04SDN0SDJBbWlJUWhJU1luejFVZHY2WHN6aXp3TXBXYUxQOTRUTWgwLXRFZFlnUlBDbk1UeGUyRzd3ZG9fZE5xREFuX2dEajFTX1lKV0R0VkRpQQ?oc=5","date":"2020-10-27","type":"pipeline","source":"Fierce Biotech","summary":"Catabasis DMD effort fails again as it cuts drug from pipeline, considers 'strategic options' - Fierce Biotech","headline":"Catabasis DMD effort fails again as it cuts drug from pipeline, considers 'strategic options'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQZjlQQzJFbjVDT2t4d3YtRlFOY09sQ0ZYel9fSl9JVEhqVHVwdEw0bXhiRExpNGNlcW82OWplWFVUeDl6Skl6VVhEeDJfNUN1QUg3aEZfRGRTMGROQ0NwZmdzWFE5QjBKN0dsbDFjVzR4bkh6bmZDUVowZkQ0LVVyTjQzbFVuazFhX1RKT1RxMElrcU9BSVpDRGh3?oc=5","date":"2020-09-14","type":"pipeline","source":"Fierce Biotech","summary":"Where are they now? Tracking down 2010’s Fierce 15 - Fierce Biotech","headline":"Where are they now? Tracking down 2010’s Fierce 15","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQYXE1dk1mdUxhekUtcV9NR002WWFTTTd4eTZIcDNjOTJLYy0wMmRwTmJNWWRVWkVIbkxjcDBlQldQeHhyMTR3RzNkelJ3Sk1XMFlVNFBZRXNmd3A3ck0xbVQwWWFtSnUwVmExNUFSOWt4RGk2WFFSUWRlYUNrSHZscldVLWhNdw?oc=5","date":"2018-03-15","type":"pipeline","source":"The New York Times","summary":"Opinion | Theranos’s Fraud Tested the Limits of the Disruption Tale (Published 2018) - The New York Times","headline":"Opinion | Theranos’s Fraud Tested the Limits of the Disruption Tale (Published 2018)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE05THk4TXhKODY2Z094Vk9CdjZRMDJ6aXhQTm9iMkRvTzMzbkFtQnl1bFBkRFFnbjhxZE53OHZsMzlhVmtLblFmZm1kT1hsMGVWVUV5Vnh5R08xSV9XMVp5Ymg4eUs?oc=5","date":"2015-04-01","type":"pipeline","source":"Pharma Voice","summary":"Talent Pool - Pharma Voice","headline":"Talent Pool","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}